Annual EBIT
-$213.03 M
-$57.96 M-37.38%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual earnings before interest & taxes is -$213.03 million, with the most recent change of -$57.96 million (-37.38%) on November 30, 2024.
- During the last 3 years, NRIX annual EBIT has fallen by -$95.14 million (-80.71%).
- NRIX annual EBIT is now -2087.36% below its all-time high of -$9.74 million, reached on November 30, 2018.
Performance
NRIX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$64.66 M
-$10.05 M-18.40%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly earnings before interest & taxes is -$64.66 million, with the most recent change of -$10.05 million (-18.40%) on November 30, 2024.
- Over the past year, NRIX quarterly EBIT has dropped by -$19.44 million (-42.99%).
- NRIX quarterly EBIT is now -2375.38% below its all-time high of -$2.61 million, reached on August 31, 2019.
Performance
NRIX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$213.03 M
-$19.32 M-9.98%
November 30, 2024
Summary
- As of February 8, 2025, NRIX TTM earnings before interest & taxes is -$213.03 million, with the most recent change of -$19.32 million (-9.98%) on November 30, 2024.
- Over the past year, NRIX TTM EBIT has dropped by -$55.70 million (-35.40%).
- NRIX TTM EBIT is now -8055.70% below its all-time high of -$2.61 million, reached on August 31, 2019.
Performance
NRIX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NRIX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.4% | -43.0% | -35.4% |
| 3 y3 years | -80.7% | -50.5% | -15.7% |
| 5 y5 years | -858.0% | -50.5% | -15.7% |
NRIX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -80.7% | at low | -141.6% | at low | -80.7% | at low |
| 5 y | 5-year | -858.0% | at low | -415.1% | at low | -1216.9% | at low |
| alltime | all time | -2087.4% | at low | -2375.4% | at low | -8055.7% | at low |
Nurix Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | -$213.03 M(+37.4%) | -$64.66 M(+18.4%) | -$213.03 M(+10.0%) |
| Aug 2024 | - | -$54.61 M(+12.5%) | -$193.70 M(+8.2%) |
| May 2024 | - | -$48.54 M(+7.3%) | -$179.10 M(+13.8%) |
| Feb 2024 | - | -$45.22 M(-0.3%) | -$157.33 M(+1.5%) |
| Nov 2023 | -$155.06 M(-15.7%) | -$45.33 M(+13.3%) | -$155.06 M(-2.1%) |
| Aug 2023 | - | -$40.01 M(+49.5%) | -$158.42 M(-4.1%) |
| May 2023 | - | -$26.77 M(-37.7%) | -$165.13 M(-10.3%) |
| Feb 2023 | - | -$42.95 M(-11.8%) | -$184.07 M(+0.1%) |
| Nov 2022 | -$183.87 M | -$48.69 M(+4.2%) | -$183.87 M(+6.2%) |
| Aug 2022 | - | -$46.72 M(+2.2%) | -$173.13 M(+11.4%) |
| May 2022 | - | -$45.72 M(+7.0%) | -$155.41 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2022 | - | -$42.74 M(+12.6%) | -$136.11 M(+15.5%) |
| Nov 2021 | -$117.89 M(+81.4%) | -$37.95 M(+30.9%) | -$117.89 M(+18.0%) |
| Aug 2021 | - | -$29.00 M(+9.8%) | -$99.94 M(+10.9%) |
| May 2021 | - | -$26.41 M(+7.7%) | -$90.14 M(+17.1%) |
| Feb 2021 | - | -$24.52 M(+22.6%) | -$76.95 M(+18.4%) |
| Nov 2020 | -$64.98 M(+192.2%) | -$20.01 M(+4.3%) | -$64.98 M(+11.0%) |
| Aug 2020 | - | -$19.19 M(+45.1%) | -$58.54 M(+39.5%) |
| May 2020 | - | -$13.23 M(+5.4%) | -$41.96 M(+46.1%) |
| Feb 2020 | - | -$12.55 M(-7.5%) | -$28.73 M(+77.6%) |
| Nov 2019 | -$22.24 M(+128.3%) | -$13.56 M(+419.3%) | -$16.18 M(+519.3%) |
| Aug 2019 | - | -$2.61 M | -$2.61 M |
| Nov 2018 | -$9.74 M | - | - |
FAQ
- What is Nurix Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Nurix Therapeutics?
- What is Nurix Therapeutics annual EBIT year-on-year change?
- What is Nurix Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly EBIT year-on-year change?
- What is Nurix Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Nurix Therapeutics?
- What is Nurix Therapeutics TTM EBIT year-on-year change?
What is Nurix Therapeutics annual earnings before interest & taxes?
The current annual EBIT of NRIX is -$213.03 M
What is the all time high annual EBIT for Nurix Therapeutics?
Nurix Therapeutics all-time high annual earnings before interest & taxes is -$9.74 M
What is Nurix Therapeutics annual EBIT year-on-year change?
Over the past year, NRIX annual earnings before interest & taxes has changed by -$57.96 M (-37.38%)
What is Nurix Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of NRIX is -$64.66 M
What is the all time high quarterly EBIT for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly earnings before interest & taxes is -$2.61 M
What is Nurix Therapeutics quarterly EBIT year-on-year change?
Over the past year, NRIX quarterly earnings before interest & taxes has changed by -$19.44 M (-42.99%)
What is Nurix Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of NRIX is -$213.03 M
What is the all time high TTM EBIT for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM earnings before interest & taxes is -$2.61 M
What is Nurix Therapeutics TTM EBIT year-on-year change?
Over the past year, NRIX TTM earnings before interest & taxes has changed by -$55.70 M (-35.40%)